N-deglycosylation of human complement component C9 reduces its hemolytic activity

R Kontermann1, E W Rauterberg

  • 1Institute of Immunology, University of Heidelberg, F.R.G.

Molecular Immunology
|December 1, 1989
PubMed
Summary

Enzymatic deglycosylation of human complement component C9 (complement C9) significantly reduced its hemolytic activity. N-linked carbohydrates on C9 are crucial for its full hemolytic function.

Related Concept Videos